PM

Over the past six months, Philip Morris International's stock experienced several notable events: Q1 2026 earnings were released on April 22, 2026, reporting an EPS of $1.56. An Annual General Meeting was held on May 6, 2026. The stock price reached a 7-week high of $171.84 on May 8, 2026, coinciding with the announcement of a Group CFO succession. IQOS was recognized as one of the most valuable global brands by Kantar's BrandZ 2026 Ranking on May 20, 2026. Robust Q2 2026 results were reported on July 22, 2026, with adjusted diluted EPS growing 15.2% to $2.20 and revenue of $11.19 billion, contributing to a 5% stock gain since June 30, 2026. Shares decreased to a 7-week low of $183.91 on September 4, 2026. On September 18, 2026, the company increased its dividend by 8.8% to an annualized rate of $6.40 per share, attracting institutional buying. Recent U.S. FDA authorization for ZYN nicotine pouches underscored the strength of its smoke-free portfolio and contributed to stock appreciation. On October 8, 2026, shares rose 4.0% to $200.50, reflecting a 29.1% gain over the past 12 months and 8.5% in the last month. Despite strong performance, the stock was considered overvalued on October 8, 2026, trading 25.8% above its GF Value™ estimate with a significantly higher P/E ratio than its 5-year median.